Filing Details
- Accession Number:
- 0001567619-21-020776
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-11-18 17:46:35
- Reporting Period:
- 2021-11-17
- Accepted Time:
- 2021-11-18 17:46:35
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1439725 | Biodesix Inc | BDSX | Services-Medical Laboratories (8071) | 203986492 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1697361 | Scott Hutton | 2970 Wilderness Place Suite 100 Boulder CO 80301 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-11-17 | 3,000 | $6.46 | 9,762 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares of Common Stock were purchased in multiple transactions at prices ranging from $6.23 to $6.57, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.
- Includes 1,262 shares acquired under the BDSX stock purchase plan on August 31, 2021.
Billionaire Hedge Funds
